Skip to main content
logo
CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.50
-0.75 (-6.67%)
Sep 4, 2026, 4:34 PM GMT

CRISM Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
65411424
Market Cap Growth
45.41%43.92%186.75%-91.00%-40.80%6.56%
Enterprise Value
552-51022
Last Close Price
0.110.100.110.140.030.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.4122.40143.7827.86--
PB Ratio
4.313.652.44-2.090.601.06
P/TBV Ratio
4.653.942.57-0.601.06

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
21.5320.8969.30---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----1.16--
Net Debt / Equity Ratio
-0.80-0.80-0.87-1.16-0.12-0.22
Net Debt / EBITDA Ratio
0.610.611.48-4.521.794.42
Net Debt / FCF Ratio
0.570.571.37-7.100.992.96
Asset Turnover
0.130.130.030.00--
Quick Ratio
3.603.603.910.033.786.03
Current Ratio
4.354.354.960.0331.2127.72
Return on Equity (ROE)
-129.78%-129.78%-135.70%-1.85%-8.99%-5.83%
Return on Assets (ROA)
-64.97%-64.97%-56.61%-0.94%-4.63%-3.51%
Return on Capital Employed (ROCE)
-132.60%-132.60%-59.70%57.20%-8.00%-5.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-31.19%-36.78%-16.89%-15.63%-17.95%-3.79%
FCF Yield
-32.24%-38.02%-25.96%-7.82%-20.94%-7.09%
Buyback Yield / Dilution
-500.23%-13.32%-201033.86%99.82%-0.85%-28.82%